Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Prospective, multi-center, single arm, post approval study to be conducted in the United States.
Evaluate the effectiveness of Boston Scientific (BSC)'s LV MSP (Left Ventricular MultiSite Pacing) feature in the Resonate family of CRT-D devices and confirm safety in a post approval study when used in accordance with its approved labeling.
Inclusion Criteria:
Exclusion Criteria:
Saginaw, Michigan 48601, United States